AppYea

AppYea R&D Expenses

Delisted·Sep 22, 2026

The Research & Development Expenses of AppYea (APYP) as of Oct 31, 2026 is 240,000.00 USD. In the previous year, Research & Development Expenses was 339,000.00 USD — a change of -29.20% (lower).

R&D Expenses

240,000.00USD

YoY

-29.20%

Last updated:

Research & Development Expenses of AppYea is 2025 240,000.00 USD. Research & Development Expenses of AppYea was 2024 339,000.00 USD. It decreases by -29.20% lower compared to the previous year.

The AppYea R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2021
81,000.00 USD
Jan 1, 2022
129,000.00 USD
Jan 1, 2023
124,000.00 USD
Jan 1, 2024
339,000.00 USD
Jan 1, 2025
240,000.00 USD
The AppYea R&D Expenses history
YEARR&D ExpensesYoY
240,000.00USD-29.20%
339,000.00USD+173.39%
124,000.00USD-3.88%
129,000.00USD+59.26%
81,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AppYea Stock analysis

What does AppYea do? AppYea Inc develops wearable monitoring solutions for sleep apnea and snoring treatment, focusing on the DreamIT wristband for snoring biofeedback and the DreamIT PRO wristband for sleep apnea treatment. The SleepX App monitors physiological parameters during sleep using algorithms developed by SleepX, while SleepX PRO is a medical application that identifies sleep apnea episodes without direct user contact. These products target patients seeking non-invasive sleep disorder management through wearable technology. The company's revenue streams come from direct sales of DreamIT, DreamIT PRO, and SleepX PRO to end-users, with the SleepX PRO app specifically positioned as a medical application for sleep apnea monitoring. The DreamIT and DreamIT PRO devices are sold alongside their respective apps, creating a bundled offering for consumers managing sleep-related health issues. The SleepX PRO app's medical certification enables it to be marketed as a healthcare solution rather than a general wellness tool. AppYea Inc's target market includes individuals diagnosed with sleep apnea or chronic snoring, who prefer wearable technology over traditional CPAP machines. The company positions its products as alternatives to conventional treatments, emphasizing convenience and non-invasive monitoring through the SleepX algorithms that process sensor data during sleep. Sales are driven by the medical application status of SleepX PRO, which differentiates it from consumer wellness apps. AppYea is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AppYea stock

Research & Development Expenses of AppYea is 240,000.00 USD in 2025.

Research & Development Expenses of AppYea changed from 339,000.00 USD to 240,000.00 USD, representing a -29.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses AppYea since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's AppYea historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — AppYea

All Key Metrics — AppYea